Press Releases




Cookie Policy






Market Reports




Non Profits




Biotechnology News Magazine

Emergency Nurses Association Prepares to Recharge with 51st President

2022 ENA President Jennifer Schmitz to Focus on How ER Nurses Can Recharge

- Advertisement -
Share the News

On Monday, Jennifer Schmitz, MSN, EMT-P, CEN, CPEN, CNML, FNP-C, NE-BC, took office as president of the Emergency Nurses Association.

Schmitz, of Cape Elizabeth, Maine, joined ENA in 2002 as a new graduate nurse and has been active at the local, state and national levels ever since. She served as Maine ENA State Council president and as a member of the council’s board of directors, participated on the ENA Operations Committee in 2016 and 2017, is an active TNCC and ENPC instructor, and served as a board member at the national level.

Schmitz enters 2022 with a focus on recharging ENA and its members who have experienced burnout and exhaustion as a result of the ongoing pandemic. Schmitz hopes to inspire emergency nurses to find time to recharge and keep pushing forward. Furthering that inspiration, Schmitz aims to build confidence in individuals who may be hesitant to pursue a role at the local, state or national level within the association.

“I’m thrilled to lead such a great organization and look forward to the triumphs and challenges that lay ahead,” said Schmitz. “Emergency nursing is a complex profession, so it’s important for all of us to focus on recharging. Whether that’s spending time doing a hobby we love, giving back to our communities, or volunteering with the association, my goal is to provide a consistent reminder that we must take care of ourselves.”

Schmitz has spent her entire career in emergency nursing, primarily in a community hospital setting. She has served at a variety of levels and is currently the chief nursing officer for Southern Maine Health Care in Biddeford, Maine, where she still cares for patients at the stretcherside.

The 2022 ENA Board of Directors:

President: Jennifer Schmitz, MSN, EMT-P, CEN, CPEN, CNML, FNP-C, NE-BC, of Maine

President-elect: Terry Foster, MSN, RN, CEN, CPEN, CCRN, TCRN, FAEN, of Kentucky

Secretary/Treasurer: Chris Dellinger, MBA, BSN, RN, FAEN, of West Virginia


Dustin Bass, MHA, BSN, RN, CEN, BE-BC, of North Carolina

Joop Breuer, RN, FAEN, The Netherlands

Vanessa Gorman, MSN, RN, CCRN, FAEN, FCENA, of Australia

Steven J. Jewell, BSN, RN, CEN, CPEN, of Texas

Ryan Oglesby, PhD, MHA, RN, CEN, CFRN, NEA-BC, of Florida

Cheryl Randolph, MSN, RN, CEN, CPEN, CCRN, FNP-BC, TCRN, FAEN, of California

Jack Rodgers, MBA, RN, CEN, NREMT-P, FAEN, of Georgia

Immediate Past President: Ron Kraus, MSN, RN, EMT, CEN, TCRN, ACNS-BC, of Indiana

Emerging Professional Liaison: Amie Porcelli, BSN, RN, CEN, TCRN, of Pennsylvania

Chief Executive Officer: Nancy MacRae, MS, of Illinois


OKAY Industries Promotes Danielle Koonz to Strategic Accounts Manager

“Danielle is a dedicated team member, adept at fostering relationships with our strategic business partners and internal customers while exemplifying our company values,” said Sean Stowik, Director of Sales and Marketing. 

Dr. Yehia Hashad New EVP of R & D & CMO at Bausch + Lomb Corporation

Dr. Yehia Hashad will join Bausch + Lomb from Allergan/AbbVie, where for the past 11 years he held various roles, including leading Allergan's global clinical development program for its eye care portfolio.

Babson Diagnostics New Executive Hires

“I am excited with the level of passion, talent, and expertise we have brought to Babson,” said David Stein, chief executive officer. “These executives all possess strong backgrounds in healthcare, as well as a passion for advancing our values. They will help us achieve our vision of making routine blood testing easier, more accessible and less invasive.”

FDA Updates

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon

Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, “We remain committed to expanding our portfolio of differentiated products that help physicians deliver improved outcomes for patients with complex coronary artery disease.

Nevro Reports FDA Approval for Expanded Labeling for Senza® Spinal Cord Stimulation System

This approval is specific to Nevro's proprietary 10 kHz Therapy and differentiates Nevro's Senza System as the only SCS system with specific labeling to treat NSRBP patients.

Endomina System, a New Suturing Tool for Use by Gastroenterologists Receives FDA Clearance

“This technology is a very meaningful addition to our armamentarium for performing procedures requiring suturing,” said Dr Ivo Boškoski from Policlinico Gemelli, Rome, Italy.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Diagnostic Imaging

Philips Integrates Cloud-based AI and 3D Mapping into its Mobile C-arm System Series – Zenition

“By partnering with Philips to bring our Cydar EV Maps solution to Philips’ user-friendly Zenition platform of mobile C-arms, we are a step closer to achieving our mission to ensure every image-guided minimally-invasive surgical procedure goes exactly as planned,” said Paul Mussenden, CEO of Cydar.

Clario and XingImaging Expand Partnership

The new expanded offering leverages the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China, including amyloid, tau, and other targets.


Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology

The study met the safety and feasibility endpoints and suggests for the first time that with the preCARDIA system it is possible to rapidly reduce cardiac filling pressures and augment urine output by intermittently occluding the superior vena cava in patients with ADHF

Patient Enrollment is Complete in the DOD-Funded Study of Extracorporeal Hemopurification of Critically Ill COVID-19 Patients

“We expect the first peer-reviewed PURIFY-OBS clinical trial publication soon, now that the study has concluded. We are pleased to see these consistent and very positive results and we’re pleased to know we have helped save the lives of many critically-ill COVID-19 patients,” said ExThera Medical CEO Robert Ward.

Other News

Cook Medical Receives FDA Breakthrough Designation for New Drug-eluting Stent

The Breakthrough Device designation is granted for devices that have the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases or conditions.

Montecito Medical Acquires Perimeter Center Commons

“This outstanding asset has all of the key attributes we look for in strategically acquiring medical office properties,” said Bryan Brown, Senior Vice President of Acquisitions at Montecito Medical.

By using this website you agree to accept Medical Device News Magazine Privacy Policy






Receive A Week in Review Newsletter

Every Friday. It's Free!